Publisher: Endocrinology Advisor

This study included 64 women aged 24 to 66 years, all of whom had type 2 diabetes; the group’s average hemoglobin A1C (HbA1C) at diagnosis was 6.4% (range 5.8% to 13.2%), said Laura Reed, DNP, APRN, FNP-BC, CDC, of the College of Nursing, The University of Tennessee Health Science Center in Memphis.

‘There is some suggestion that obese patients may be different in how they metabolize drugs. There may be a difference in pharmacokinetics,’ said endocrinologist Kathleen Glymph, MD, who is with the University of Tennessee Health Science Center in Memphis.